Hypermarcas PE Ratio 2009-2019 | HYPMY

Current and historical p/e ratio for Hypermarcas (HYPMY) from 2009 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hypermarcas PE ratio as of February 25, 2020 is 16.33.
Hypermarcas PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.368B $0.978B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.726B 38.02
Takeda Pharmaceutical (TAK) Japan $56.981B 10.10
Astellas Pharma (ALPMY) Japan $30.920B 15.44
Eisai (ESALY) Japan $22.211B 42.82
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $17.010B 22.29
Merck (MKGAF) Germany $16.730B 22.83
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $8.946B 248.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $8.188B 33.69
Ionis Pharmaceuticals (IONS) United States $8.032B 16.27
Jazz Pharmaceuticals (JAZZ) Ireland $7.403B 9.46
IPSEN SA ADR (IPSEY) France $5.891B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
United Therapeutics (UTHR) United States $5.062B 0.00
Nektar Therapeutics (NKTR) United States $3.934B 0.00
FibroGen (FGEN) United States $3.803B 111.77
Evotec AG (EVTCY) Germany $3.797B 61.27
Arrowhead Pharmaceuticals (ARWR) United States $3.699B 68.66
Sage Therapeutics (SAGE) United States $3.479B 0.00
PTC Therapeutics (PTCT) United States $3.383B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.822B 11.42
ChemoCentryx (CCXI) United States $2.728B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.153B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.983B 54.23
Xencor (XNCR) United States $1.890B 77.49
Heron Therapeutics (HRTX) United States $1.885B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.784B 21.68
Tilray (TLRY) Canada $1.738B 0.00
Corcept Therapeutics (CORT) United States $1.519B 17.04
USANA Health Sciences (USNA) United States $1.456B 15.22
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Endo (ENDP) Ireland $1.361B 2.50
Theravance Biopharma (TBPH) Cayman Islands $1.334B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.328B 9.06
Zogenix (ZGNX) United States $1.279B 0.00
Akebia Therapeutics (AKBA) United States $1.188B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.025B 31.75
Portola Pharmaceuticals (PTLA) United States $1.016B 0.00
Aerie Pharmaceuticals (AERI) United States $0.940B 0.00
Karyopharm Therapeutics (KPTI) United States $0.929B 0.00
Radius Health (RDUS) United States $0.881B 0.00
Collegium Pharmaceutical (COLL) United States $0.796B 0.00
ImmunoGen (IMGN) United States $0.762B 0.00
Molecular Templates (MTEM) United States $0.633B 0.00
Flexion Therapeutics (FLXN) United States $0.620B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.548B 0.00
TherapeuticsMD (TXMD) United States $0.515B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.506B 61.38
Ardelyx (ARDX) United States $0.501B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.450B 19.40
Innate Pharma SA (IPHYF) France $0.446B 0.00
Translate Bio (TBIO) United States $0.441B 0.00
Organogenesis Holdings (ORGO) United States $0.424B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.407B 0.00
Calithera Biosciences (CALA) United States $0.404B 0.00
DURECT (DRRX) United States $0.402B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.398B 0.00
Lannett Co Inc (LCI) United States $0.378B 6.08
Siga Technologies (SIGA) United States $0.371B 8.46
Rigel Pharmaceuticals (RIGL) United States $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.362B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.357B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.356B 0.00
Recro Pharma (REPH) United States $0.355B 0.00
Indivior (INVVY) United States $0.353B 2.10
Rafael Holdings (RFL) United States $0.323B 0.00
Concert Pharmaceuticals (CNCE) United States $0.321B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.316B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.309B 0.00
OptiNose (OPTN) United States $0.288B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.248B 0.00
Ocular Therapeutix (OCUL) United States $0.247B 0.00
IMV INC (IMV) Canada $0.242B 0.00
MEI Pharma (MEIP) United States $0.242B 0.00
KalVista Pharmaceuticals (KALV) United States $0.237B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.194B 33.47
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.194B 0.00
Jounce Therapeutics (JNCE) United States $0.191B 2.56
Galmed Pharmaceuticals (GLMD) Israel $0.126B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
CannTrust Holdings (CTST) Canada $0.113B 0.00
Xeris Pharmaceuticals (XERS) United States $0.111B 0.00
Otonomy (OTIC) United States $0.106B 0.00
Redhill Biopharma (RDHL) Israel $0.103B 0.00
Aquestive Therapeutics (AQST) United States $0.102B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.094B 0.00
CV Sciences (CVSI) United States $0.080B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
MediWound (MDWD) Israel $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Infinity Pharmaceuticals (INFI) United States $0.076B 0.00
Onconova Therapeutics (ONTX) United States $0.072B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.067B 20.05
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
CTI BioPharma (CTIC) United States $0.063B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
VAXART, INC (VXRT) United States $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
IsoRay (ISR) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.050B 22.81
AgeX Therapeutics (AGE) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Vical (BBI) United States $0.027B 0.00
Cardiome Pharma (CORV) Canada $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Shineco (TYHT) China $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Novan (NOVN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00